vs
欧加隆（OGN）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是利氏兄弟拍卖行的1.3倍（$1.5B vs $1.2B），利氏兄弟拍卖行净利率更高（9.1% vs -13.6%，领先22.7%），利氏兄弟拍卖行同比增速更快（5.4% vs -5.3%），利氏兄弟拍卖行自由现金流更多（$186.5M vs $96.0M），过去两年利氏兄弟拍卖行的营收复合增速更高（6.3% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
OGN vs RBA — 直观对比
营收规模更大
OGN
是对方的1.3倍
$1.2B
营收增速更快
RBA
高出10.8%
-5.3%
净利率更高
RBA
高出22.7%
-13.6%
自由现金流更多
RBA
多$90.5M
$96.0M
两年增速更快
RBA
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.2B |
| 净利润 | $-205.0M | $109.7M |
| 毛利率 | 49.2% | — |
| 营业利润率 | -9.8% | 14.7% |
| 净利率 | -13.6% | 9.1% |
| 营收同比 | -5.3% | 5.4% |
| 净利润同比 | -288.1% | -7.4% |
| 每股收益（稀释后） | $-0.78 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNRBA
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $981.8M | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
净利润OGNRBA
| Q4 25 | $-205.0M | $109.7M | ||
| Q3 25 | $160.0M | $95.5M | ||
| Q2 25 | $145.0M | $109.8M | ||
| Q1 25 | $87.0M | $113.4M | ||
| Q4 24 | $109.0M | $118.5M | ||
| Q3 24 | $359.0M | $76.1M | ||
| Q2 24 | $195.0M | $111.1M | ||
| Q1 24 | $201.0M | $107.4M |
毛利率OGNRBA
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
营业利润率OGNRBA
| Q4 25 | -9.8% | 14.7% | ||
| Q3 25 | 15.2% | 14.5% | ||
| Q2 25 | 14.4% | 15.9% | ||
| Q1 25 | 6.7% | 17.1% | ||
| Q4 24 | 8.1% | 18.1% | ||
| Q3 24 | 13.1% | 15.6% | ||
| Q2 24 | 14.6% | 18.4% | ||
| Q1 24 | 14.5% | 18.7% |
净利率OGNRBA
| Q4 25 | -13.6% | 9.1% | ||
| Q3 25 | 10.0% | 8.7% | ||
| Q2 25 | 9.1% | 9.3% | ||
| Q1 25 | 5.8% | 10.2% | ||
| Q4 24 | 6.8% | 10.4% | ||
| Q3 24 | 22.7% | 7.8% | ||
| Q2 24 | 12.1% | 10.1% | ||
| Q1 24 | 12.4% | 10.1% |
每股收益（稀释后）OGNRBA
| Q4 25 | $-0.78 | $0.53 | ||
| Q3 25 | $0.61 | $0.43 | ||
| Q2 25 | $0.56 | $0.53 | ||
| Q1 25 | $0.33 | $0.55 | ||
| Q4 24 | $0.42 | $0.58 | ||
| Q3 24 | $1.38 | $0.36 | ||
| Q2 24 | $0.75 | $0.54 | ||
| Q1 24 | $0.78 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $531.5M |
| 总债务越低越好 | $8.6B | $2.3B |
| 股东权益账面价值 | $752.0M | $5.6B |
| 总资产 | $12.9B | $12.1B |
| 负债/权益比越低杠杆越低 | 11.49× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资OGNRBA
| Q4 25 | $574.0M | $531.5M | ||
| Q3 25 | $672.0M | $674.7M | ||
| Q2 25 | $599.0M | $710.2M | ||
| Q1 25 | $547.0M | $578.1M | ||
| Q4 24 | $675.0M | $533.9M | ||
| Q3 24 | $763.0M | $650.7M | ||
| Q2 24 | $704.0M | $599.5M | ||
| Q1 24 | $575.0M | $462.8M |
总债务OGNRBA
| Q4 25 | $8.6B | $2.3B | ||
| Q3 25 | $8.8B | $2.6B | ||
| Q2 25 | $8.9B | $2.6B | ||
| Q1 25 | $9.0B | $2.6B | ||
| Q4 24 | $8.9B | $2.6B | ||
| Q3 24 | $8.7B | $2.7B | ||
| Q2 24 | $8.7B | $2.8B | ||
| Q1 24 | $8.7B | $2.9B |
股东权益OGNRBA
| Q4 25 | $752.0M | $5.6B | ||
| Q3 25 | $906.0M | $5.5B | ||
| Q2 25 | $733.0M | $5.5B | ||
| Q1 25 | $542.0M | $5.3B | ||
| Q4 24 | $472.0M | $5.2B | ||
| Q3 24 | $493.0M | $5.2B | ||
| Q2 24 | $144.0M | $5.2B | ||
| Q1 24 | $48.0M | $5.1B |
总资产OGNRBA
| Q4 25 | $12.9B | $12.1B | ||
| Q3 25 | $13.6B | $12.2B | ||
| Q2 25 | $13.5B | $12.2B | ||
| Q1 25 | $13.2B | $11.9B | ||
| Q4 24 | $13.1B | $11.8B | ||
| Q3 24 | $12.8B | $11.9B | ||
| Q2 24 | $12.2B | $12.1B | ||
| Q1 24 | $11.9B | $12.0B |
负债/权益比OGNRBA
| Q4 25 | 11.49× | 0.42× | ||
| Q3 25 | 9.74× | 0.47× | ||
| Q2 25 | 12.14× | 0.47× | ||
| Q1 25 | 16.52× | 0.50× | ||
| Q4 24 | 18.81× | 0.50× | ||
| Q3 24 | 17.75× | 0.52× | ||
| Q2 24 | 60.11× | 0.55× | ||
| Q1 24 | 181.54× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $255.2M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $186.5M |
| 自由现金流率自由现金流/营收 | 6.4% | 15.5% |
| 资本支出强度资本支出/营收 | 3.0% | 5.7% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | $538.0M | $719.2M |
8季度趋势，按日历期对齐
经营现金流OGNRBA
| Q4 25 | $141.0M | $255.2M | ||
| Q3 25 | $264.0M | $239.7M | ||
| Q2 25 | $220.0M | $326.5M | ||
| Q1 25 | $75.0M | $156.8M | ||
| Q4 24 | $390.0M | $184.5M | ||
| Q3 24 | $141.0M | $285.4M | ||
| Q2 24 | $332.0M | $337.3M | ||
| Q1 24 | $76.0M | $124.8M |
自由现金流OGNRBA
| Q4 25 | $96.0M | $186.5M | ||
| Q3 25 | $218.0M | $188.5M | ||
| Q2 25 | $181.0M | $241.7M | ||
| Q1 25 | $43.0M | $102.5M | ||
| Q4 24 | $335.0M | $127.9M | ||
| Q3 24 | $99.0M | $248.5M | ||
| Q2 24 | $300.0M | $308.6M | ||
| Q1 24 | $30.0M | $79.6M |
自由现金流率OGNRBA
| Q4 25 | 6.4% | 15.5% | ||
| Q3 25 | 13.6% | 17.3% | ||
| Q2 25 | 11.4% | 20.4% | ||
| Q1 25 | 2.8% | 9.2% | ||
| Q4 24 | 21.0% | 11.2% | ||
| Q3 24 | 6.3% | 25.3% | ||
| Q2 24 | 18.7% | 28.2% | ||
| Q1 24 | 1.8% | 7.5% |
资本支出强度OGNRBA
| Q4 25 | 3.0% | 5.7% | ||
| Q3 25 | 2.9% | 4.7% | ||
| Q2 25 | 2.4% | 7.2% | ||
| Q1 25 | 2.1% | 4.9% | ||
| Q4 24 | 3.5% | 5.0% | ||
| Q3 24 | 2.7% | 3.8% | ||
| Q2 24 | 2.0% | 2.6% | ||
| Q1 24 | 2.8% | 4.2% |
现金转化率OGNRBA
| Q4 25 | — | 2.33× | ||
| Q3 25 | 1.65× | 2.51× | ||
| Q2 25 | 1.52× | 2.97× | ||
| Q1 25 | 0.86× | 1.38× | ||
| Q4 24 | 3.58× | 1.56× | ||
| Q3 24 | 0.39× | 3.75× | ||
| Q2 24 | 1.70× | 3.04× | ||
| Q1 24 | 0.38× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OGN
暂无分部数据
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
